img

Global TD Vaccine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global TD Vaccine Market Insights, Forecast to 2034

Td vaccine can prevent tetanus and diphtheria.
The global TD Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for TD Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for TD Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for TD Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of TD Vaccine include Sanofi, Grifols, GSK, Biological E Limited, Incepta Pharma and BB-NCIPD Ltd., etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for TD Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of TD Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for TD Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the TD Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global TD Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for TD Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, Grifols, GSK, Biological E Limited, Incepta Pharma and BB-NCIPD Ltd., etc.



By Company


Sanofi
Grifols
GSK
Biological E Limited
Incepta Pharma
BB-NCIPD Ltd.
Segment by Type
3-dose Series
More than 3-dose Series

Segment by Application


TETANUS (T)
DIPITHERIA (D)

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of TD Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of TD Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, TD Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 TD Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global TD Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 3-dose Series
1.2.3 More than 3-dose Series
1.3 Market by Application
1.3.1 Global TD Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 TETANUS (T)
1.3.3 DIPITHERIA (D)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global TD Vaccine Sales Estimates and Forecasts 2018-2034
2.2 Global TD Vaccine Revenue by Region
2.2.1 Global TD Vaccine Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global TD Vaccine Revenue by Region (2018-2024)
2.2.3 Global TD Vaccine Revenue by Region (2024-2034)
2.2.4 Global TD Vaccine Revenue Market Share by Region (2018-2034)
2.3 Global TD Vaccine Sales Estimates and Forecasts 2018-2034
2.4 Global TD Vaccine Sales by Region
2.4.1 Global TD Vaccine Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global TD Vaccine Sales by Region (2018-2024)
2.4.3 Global TD Vaccine Sales by Region (2024-2034)
2.4.4 Global TD Vaccine Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global TD Vaccine Sales by Manufacturers
3.1.1 Global TD Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global TD Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of TD Vaccine in 2022
3.2 Global TD Vaccine Revenue by Manufacturers
3.2.1 Global TD Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global TD Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by TD Vaccine Revenue in 2022
3.3 Global Key Players of TD Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global TD Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global TD Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of TD Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of TD Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of TD Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global TD Vaccine Sales by Type
4.1.1 Global TD Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global TD Vaccine Forecasted Sales by Type (2024-2034)
4.1.3 Global TD Vaccine Sales Market Share by Type (2018-2034)
4.2 Global TD Vaccine Revenue by Type
4.2.1 Global TD Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global TD Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global TD Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global TD Vaccine Price by Type
4.3.1 Global TD Vaccine Price by Type (2018-2024)
4.3.2 Global TD Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global TD Vaccine Sales by Application
5.1.1 Global TD Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global TD Vaccine Forecasted Sales by Application (2024-2034)
5.1.3 Global TD Vaccine Sales Market Share by Application (2018-2034)
5.2 Global TD Vaccine Revenue by Application
5.2.1 Global TD Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global TD Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global TD Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global TD Vaccine Price by Application
5.3.1 Global TD Vaccine Price by Application (2018-2024)
5.3.2 Global TD Vaccine Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada TD Vaccine Market Size by Type
6.1.1 US & Canada TD Vaccine Sales by Type (2018-2034)
6.1.2 US & Canada TD Vaccine Revenue by Type (2018-2034)
6.2 US & Canada TD Vaccine Market Size by Application
6.2.1 US & Canada TD Vaccine Sales by Application (2018-2034)
6.2.2 US & Canada TD Vaccine Revenue by Application (2018-2034)
6.3 US & Canada TD Vaccine Market Size by Country
6.3.1 US & Canada TD Vaccine Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada TD Vaccine Sales by Country (2018-2034)
6.3.3 US & Canada TD Vaccine Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe TD Vaccine Market Size by Type
7.1.1 Europe TD Vaccine Sales by Type (2018-2034)
7.1.2 Europe TD Vaccine Revenue by Type (2018-2034)
7.2 Europe TD Vaccine Market Size by Application
7.2.1 Europe TD Vaccine Sales by Application (2018-2034)
7.2.2 Europe TD Vaccine Revenue by Application (2018-2034)
7.3 Europe TD Vaccine Market Size by Country
7.3.1 Europe TD Vaccine Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe TD Vaccine Sales by Country (2018-2034)
7.3.3 Europe TD Vaccine Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China TD Vaccine Market Size
8.1.1 China TD Vaccine Sales (2018-2034)
8.1.2 China TD Vaccine Revenue (2018-2034)
8.2 China TD Vaccine Market Size by Application
8.2.1 China TD Vaccine Sales by Application (2018-2034)
8.2.2 China TD Vaccine Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia TD Vaccine Market Size by Type
9.1.1 Asia TD Vaccine Sales by Type (2018-2034)
9.1.2 Asia TD Vaccine Revenue by Type (2018-2034)
9.2 Asia TD Vaccine Market Size by Application
9.2.1 Asia TD Vaccine Sales by Application (2018-2034)
9.2.2 Asia TD Vaccine Revenue by Application (2018-2034)
9.3 Asia TD Vaccine Sales by Region
9.3.1 Asia TD Vaccine Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia TD Vaccine Revenue by Region (2018-2034)
9.3.3 Asia TD Vaccine Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America TD Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America TD Vaccine Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America TD Vaccine Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America TD Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America TD Vaccine Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America TD Vaccine Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America TD Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America TD Vaccine Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America TD Vaccine Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America TD Vaccine Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi TD Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi TD Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Grifols
11.2.1 Grifols Company Information
11.2.2 Grifols Overview
11.2.3 Grifols TD Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Grifols TD Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Overview
11.3.3 GSK TD Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GSK TD Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 Biological E Limited
11.4.1 Biological E Limited Company Information
11.4.2 Biological E Limited Overview
11.4.3 Biological E Limited TD Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Biological E Limited TD Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biological E Limited Recent Developments
11.5 Incepta Pharma
11.5.1 Incepta Pharma Company Information
11.5.2 Incepta Pharma Overview
11.5.3 Incepta Pharma TD Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Incepta Pharma TD Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Incepta Pharma Recent Developments
11.6 BB-NCIPD Ltd.
11.6.1 BB-NCIPD Ltd. Company Information
11.6.2 BB-NCIPD Ltd. Overview
11.6.3 BB-NCIPD Ltd. TD Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 BB-NCIPD Ltd. TD Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BB-NCIPD Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 TD Vaccine Industry Chain Analysis
12.2 TD Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 TD Vaccine Production Mode & Process
12.4 TD Vaccine Sales and Marketing
12.4.1 TD Vaccine Sales Channels
12.4.2 TD Vaccine Distributors
12.5 TD Vaccine Customers
13 Market Dynamics
13.1 TD Vaccine Industry Trends
13.2 TD Vaccine Market Drivers
13.3 TD Vaccine Market Challenges
13.4 TD Vaccine Market Restraints
14 Key Findings in The Global TD Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global TD Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 3-dose Series
Table 3. Major Manufacturers of More than 3-dose Series
Table 4. Global TD Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global TD Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global TD Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global TD Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global TD Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global TD Vaccine Revenue Market Share by Region (2024-2034)
Table 10. Global TD Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global TD Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global TD Vaccine Sales by Region (2024-2034) & (K Units)
Table 13. Global TD Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global TD Vaccine Sales Market Share by Region (2024-2034)
Table 15. Global TD Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global TD Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global TD Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global TD Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of TD Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. TD Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global TD Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global TD Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TD Vaccine as of 2022)
Table 23. Global Key Manufacturers of TD Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of TD Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of TD Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global TD Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global TD Vaccine Sales by Type (2024-2034) & (K Units)
Table 29. Global TD Vaccine Sales Share by Type (2018-2024)
Table 30. Global TD Vaccine Sales Share by Type (2024-2034)
Table 31. Global TD Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global TD Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global TD Vaccine Revenue Share by Type (2018-2024)
Table 34. Global TD Vaccine Revenue Share by Type (2024-2034)
Table 35. TD Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global TD Vaccine Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global TD Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global TD Vaccine Sales by Application (2024-2034) & (K Units)
Table 39. Global TD Vaccine Sales Share by Application (2018-2024)
Table 40. Global TD Vaccine Sales Share by Application (2024-2034)
Table 41. Global TD Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global TD Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global TD Vaccine Revenue Share by Application (2018-2024)
Table 44. Global TD Vaccine Revenue Share by Application (2024-2034)
Table 45. TD Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global TD Vaccine Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada TD Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada TD Vaccine Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada TD Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada TD Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada TD Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada TD Vaccine Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada TD Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada TD Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada TD Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 56. US & Canada TD Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada TD Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada TD Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada TD Vaccine Sales by Country (2024-2034) & (K Units)
Table 60. Europe TD Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe TD Vaccine Sales by Type (2024-2034) & (K Units)
Table 62. Europe TD Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe TD Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe TD Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe TD Vaccine Sales by Application (2024-2034) & (K Units)
Table 66. Europe TD Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe TD Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe TD Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 69. Europe TD Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe TD Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe TD Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe TD Vaccine Sales by Country (2024-2034) & (K Units)
Table 73. China TD Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China TD Vaccine Sales by Type (2024-2034) & (K Units)
Table 75. China TD Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China TD Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 77. China TD Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China TD Vaccine Sales by Application (2024-2034) & (K Units)
Table 79. China TD Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China TD Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia TD Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia TD Vaccine Sales by Type (2024-2034) & (K Units)
Table 83. Asia TD Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia TD Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia TD Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia TD Vaccine Sales by Application (2024-2034) & (K Units)
Table 87. Asia TD Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia TD Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia TD Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 90. Asia TD Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia TD Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia TD Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia TD Vaccine Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America TD Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America TD Vaccine Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America TD Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America TD Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America TD Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America TD Vaccine Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America TD Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America TD Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America TD Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America TD Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America TD Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America TD Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America TD Vaccine Sales by Country (2024-2034) & (K Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi TD Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi TD Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. Grifols Company Information
Table 113. Grifols Description and Major Businesses
Table 114. Grifols TD Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Grifols TD Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Grifols Recent Developments
Table 117. GSK Company Information
Table 118. GSK Description and Major Businesses
Table 119. GSK TD Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. GSK TD Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. GSK Recent Developments
Table 122. Biological E Limited Company Information
Table 123. Biological E Limited Description and Major Businesses
Table 124. Biological E Limited TD Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Biological E Limited TD Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Biological E Limited Recent Developments
Table 127. Incepta Pharma Company Information
Table 128. Incepta Pharma Description and Major Businesses
Table 129. Incepta Pharma TD Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Incepta Pharma TD Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Incepta Pharma Recent Developments
Table 132. BB-NCIPD Ltd. Company Information
Table 133. BB-NCIPD Ltd. Description and Major Businesses
Table 134. BB-NCIPD Ltd. TD Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. BB-NCIPD Ltd. TD Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. BB-NCIPD Ltd. Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. TD Vaccine Distributors List
Table 140. TD Vaccine Customers List
Table 141. TD Vaccine Market Trends
Table 142. TD Vaccine Market Drivers
Table 143. TD Vaccine Market Challenges
Table 144. TD Vaccine Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. TD Vaccine Product Picture
Figure 2. Global TD Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global TD Vaccine Market Share by Type in 2022 & 2034
Figure 4. 3-dose Series Product Picture
Figure 5. More than 3-dose Series Product Picture
Figure 6. Global TD Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global TD Vaccine Market Share by Application in 2022 & 2034
Figure 8. TETANUS (T)
Figure 9. DIPITHERIA (D)
Figure 10. TD Vaccine Report Years Considered
Figure 11. Global TD Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global TD Vaccine Revenue 2018-2034 (US$ Million)
Figure 13. Global TD Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 14. Global TD Vaccine Revenue Market Share by Region (2018-2034)
Figure 15. Global TD Vaccine Sales 2018-2034 ((K Units)
Figure 16. Global TD Vaccine Sales Market Share by Region (2018-2034)
Figure 17. US & Canada TD Vaccine Sales YoY (2018-2034) & (K Units)
Figure 18. US & Canada TD Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe TD Vaccine Sales YoY (2018-2034) & (K Units)
Figure 20. Europe TD Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China TD Vaccine Sales YoY (2018-2034) & (K Units)
Figure 22. China TD Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Asia (excluding China) TD Vaccine Sales YoY (2018-2034) & (K Units)
Figure 24. Asia (excluding China) TD Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America TD Vaccine Sales YoY (2018-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America TD Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The TD Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of TD Vaccine in the World: Market Share by TD Vaccine Revenue in 2022
Figure 29. Global TD Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global TD Vaccine Sales Market Share by Type (2018-2034)
Figure 31. Global TD Vaccine Revenue Market Share by Type (2018-2034)
Figure 32. Global TD Vaccine Sales Market Share by Application (2018-2034)
Figure 33. Global TD Vaccine Revenue Market Share by Application (2018-2034)
Figure 34. US & Canada TD Vaccine Sales Market Share by Type (2018-2034)
Figure 35. US & Canada TD Vaccine Revenue Market Share by Type (2018-2034)
Figure 36. US & Canada TD Vaccine Sales Market Share by Application (2018-2034)
Figure 37. US & Canada TD Vaccine Revenue Market Share by Application (2018-2034)
Figure 38. US & Canada TD Vaccine Revenue Share by Country (2018-2034)
Figure 39. US & Canada TD Vaccine Sales Share by Country (2018-2034)
Figure 40. U.S. TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 41. Canada TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 42. Europe TD Vaccine Sales Market Share by Type (2018-2034)
Figure 43. Europe TD Vaccine Revenue Market Share by Type (2018-2034)
Figure 44. Europe TD Vaccine Sales Market Share by Application (2018-2034)
Figure 45. Europe TD Vaccine Revenue Market Share by Application (2018-2034)
Figure 46. Europe TD Vaccine Revenue Share by Country (2018-2034)
Figure 47. Europe TD Vaccine Sales Share by Country (2018-2034)
Figure 48. Germany TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 49. France TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 50. U.K. TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 51. Italy TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 52. Russia TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 53. China TD Vaccine Sales Market Share by Type (2018-2034)
Figure 54. China TD Vaccine Revenue Market Share by Type (2018-2034)
Figure 55. China TD Vaccine Sales Market Share by Application (2018-2034)
Figure 56. China TD Vaccine Revenue Market Share by Application (2018-2034)
Figure 57. Asia TD Vaccine Sales Market Share by Type (2018-2034)
Figure 58. Asia TD Vaccine Revenue Market Share by Type (2018-2034)
Figure 59. Asia TD Vaccine Sales Market Share by Application (2018-2034)
Figure 60. Asia TD Vaccine Revenue Market Share by Application (2018-2034)
Figure 61. Asia TD Vaccine Revenue Share by Region (2018-2034)
Figure 62. Asia TD Vaccine Sales Share by Region (2018-2034)
Figure 63. Japan TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 64. South Korea TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 65. China Taiwan TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 66. Southeast Asia TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 67. India TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 68. Middle East, Africa and Latin America TD Vaccine Sales Market Share by Type (2018-2034)
Figure 69. Middle East, Africa and Latin America TD Vaccine Revenue Market Share by Type (2018-2034)
Figure 70. Middle East, Africa and Latin America TD Vaccine Sales Market Share by Application (2018-2034)
Figure 71. Middle East, Africa and Latin America TD Vaccine Revenue Market Share by Application (2018-2034)
Figure 72. Middle East, Africa and Latin America TD Vaccine Revenue Share by Country (2018-2034)
Figure 73. Middle East, Africa and Latin America TD Vaccine Sales Share by Country (2018-2034)
Figure 74. Brazil TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 75. Mexico TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 76. Turkey TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 77. Israel TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 78. GCC Countries TD Vaccine Revenue (2018-2034) & (US$ Million)
Figure 79. TD Vaccine Value Chain
Figure 80. TD Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed